Cytodyn Inc (CYDY)

[Saltz]

The reason why the SP and valuation of CYDY is at .60 is simple. Delays in enrollment and the capital raises with Paulson. I have been through three raises with Paulson because the caveat of 50% added warrants to shares purchased make more sense than investing on the open market. The downside is they kill the SP. We are fighting a double edge sword with these raises. As long as we are held prisoner to Paulson at the current SP we are stuck in reverse in terms of valuation. Until management can expedite enrollment in these P3's and produce data we will remain where we are right now and that has nothing to do with the OTC. The trend has been raise upon raise with no new data. There is no doubt Nader was very confident that we'd be further along at the end of Q1. The question now is how far behind are we and what is the real change in management with Tony C's increased responsibilities?

This next CC will either provide some real meat or a bunch tightly packaged excuses. Direct questions need to be asked to determine the current status of Pro-140 and what the realistic timelines are. The trend of delays has to be broken.